YUYUE MEDICAL(SZ:002223) Xin Lang Cai Jing·2026-01-09 06:19Group 1 - The core viewpoint of the news is that Yuyue Medical has seen a stock price increase of 5.01%, reaching 40.46 CNY per share, with a trading volume of 585 million CNY and a turnover rate of 1.56%, resulting in a total market capitalization of 40.56 billion CNY [1] - Yuyue Medical, established on October 22, 1998, and listed on April 18, 2008, specializes in the research, production, and sales of medical devices and their core components [1] - The company's main business revenue composition includes: respiratory therapy solutions (35.93%), clinical instruments and rehabilitation solutions (24.35%), home health monitoring solutions (21.77%), blood glucose management and POCT solutions (14.48%), emergency solutions and others (2.92%), and other supplementary solutions (0.56%) [1] Group 2 - From the perspective of fund holdings, one fund under Jiashi Fund has a significant position in Yuyue Medical, specifically the Jiashi CSI Medical Index Initiation A (014602), which reduced its holdings by 41,400 shares in the third quarter, now holding 129,300 shares, accounting for 2.41% of the fund's net value [2] - The Jiashi CSI Medical Index Initiation A (014602) was established on January 20, 2022, with a latest scale of 40.61 million CNY, and has achieved a year-to-date return of 7.44%, ranking 655 out of 5509 in its category [2] - The fund manager, Wang Zihan, has been in position for 4 years and 124 days, with the fund's total asset scale at 16.594 billion CNY, achieving a best return of 52.4% and a worst return of -42.07% during the tenure [2]